| Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition AA Geronikaki, AA Lagunin, DI Hadjipavlou-Litina, PT Eleftheriou, ... Journal of medicinal chemistry 51 (6), 1601-1609, 2008 | 228 | 2008 |
| Adamantane derivatives of thiazolyl-N-substituted amide, as possible non-steroidal anti-inflammatory agents O Kouatly, A Geronikaki, C Kamoutsis, D Hadjipavlou-Litina, P Eleftheriou European journal of medicinal chemistry 44 (3), 1198-1204, 2009 | 137 | 2009 |
| 2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action A Geronikaki, P Eleftheriou, P Vicini, I Alam, A Dixit, AK Saxena Journal of medicinal chemistry 51 (17), 5221-5228, 2008 | 126 | 2008 |
| Fragment-based design, docking, synthesis, biological evaluation and structure–activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as … P Eleftheriou, A Geronikaki, D Hadjipavlou-Litina, P Vicini, O Filz, ... European journal of medicinal chemistry 47, 111-124, 2012 | 94 | 2012 |
| Synthesis and in silico biological activity evaluation of new N-substituted pyrazolo-oxazin-2-one systems N Benaamane, B Nedjar-Kolli, Y Bentarzi, L Hammal, A Geronikaki, ... Bioorganic & medicinal chemistry 16 (6), 3059-3066, 2008 | 83 | 2008 |
| New analogues of butylated hydroxytoluene as anti-inflammatory and antioxidant agents GN Ziakas, EA Rekka, AM Gavalas, PT Eleftheriou, PN Kourounakis Bioorganic & medicinal chemistry 14 (16), 5616-5624, 2006 | 76 | 2006 |
| 5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation M Fesatidou, P Zagaliotis, C Camoutsis, A Petrou, P Eleftheriou, C Tratrat, ... Bioorganic & Medicinal Chemistry 26 (16), 4664-4676, 2018 | 69 | 2018 |
| PTP1b inhibition, a promising approach for the treatment of diabetes type II P Eleftheriou, A Geronikaki, A Petrou Current topics in medicinal chemistry 19 (4), 246-263, 2019 | 67 | 2019 |
| In silico evaluation of the effectivity of approved protease inhibitors against the main protease of the novel SARS-CoV-2 virus P Eleftheriou, D Amanatidou, A Petrou, A Geronikaki Molecules 25 (11), 2529, 2020 | 66 | 2020 |
| Serum antioxidant status among young, middle-aged and elderly people before and after antioxidant rich diet E Limberaki, P Eleftheriou, E Vagdatli, V Kostoglou, C Petrou Hippokratia 16 (2), 118, 2012 | 39 | 2012 |
| Application of docking analysis in the prediction and biological evaluation of the lipoxygenase inhibitory action of thiazolyl derivatives of mycophenolic acid E Tsolaki, P Eleftheriou, V Kartsev, A Geronikaki, AK Saxena Molecules 23 (7), 1621, 2018 | 38 | 2018 |
| Synthesis and pharmacochemical study of novel polyfunctional molecules combining anti-inflammatory, antioxidant, and hypocholesterolemic properties CM Doulgkeris, D Galanakis, AP Kourounakis, KC Tsiakitzis, AM Gavalas, ... Bioorganic & medicinal chemistry letters 16 (4), 825-829, 2006 | 35 | 2006 |
| Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity F Esposito, FA Ambrosio, R Maleddu, G Costa, R Rocca, E Maccioni, ... European Journal of Medicinal Chemistry 182, 111617, 2019 | 31 | 2019 |
| Design, synthesis, evaluation of antimicrobial activity and docking studies of new thiazole-based chalcones C Tratrat, M Haroun, I Xenikakis, K Liaras, E Tsolaki, P Eleftheriou, ... Current Topics in Medicinal Chemistry 19 (5), 356-375, 2019 | 30 | 2019 |
| Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo [d] thiazol-2-yl) thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism E Pitta, A Geronikaki, S Surmava, P Eleftheriou, VP Mehta, ... Journal of enzyme inhibition and medicinal chemistry 28 (1), 113-122, 2013 | 28 | 2013 |
| Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile GN Ziakas, EA Rekka, AM Gavalas, PT Eleftheriou, KC Tsiakitzis, ... Bioorganic & medicinal chemistry 13 (23), 6485-6492, 2005 | 27 | 2005 |
| Novel thiazolidin-4-ones as potential non-nucleoside inhibitors of HIV-1 reverse transcriptase A Petrou, P Eleftheriou, A Geronikaki, MG Akrivou, I Vizirianakis Molecules 24 (21), 3821, 2019 | 23 | 2019 |
| Docking analysis targeted to the whole enzyme: an application to the prediction of inhibition of PTP1B by thiomorpholine and thiazolyl derivatives CA Ganou, PT Eleftheriou, P Theodosis-Nobelos, M Fesatidou, ... SAR and QSAR in Environmental Research 29 (2), 133-149, 2018 | 23 | 2018 |
| Rational use of heterogeneous data in quantitative structure–activity relationship (QSAR) modeling of cyclooxygenase/lipoxygenase inhibitors AA Lagunin, A Geronikaki, P Eleftheriou, PV Pogodin, AV Zakharov Journal of chemical information and modeling 59 (2), 713-730, 2019 | 22 | 2019 |
| Anti-HIV agents: current status and recent trends A Geronikaki, P Eleftheriou, V Poroikov Communicable Diseases of the Developing World, 37-95, 2018 | 21 | 2018 |
